• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

WWC 蛋白通过 Hippo 激酶介导 LATS1/2 的激活,并暗示了一种肿瘤抑制策略。

WWC proteins mediate LATS1/2 activation by Hippo kinases and imply a tumor suppression strategy.

机构信息

Institute of Pediatrics, Children's Hospital of Fudan University, and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, China.

State Key Laboratory of Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China.

出版信息

Mol Cell. 2022 May 19;82(10):1850-1864.e7. doi: 10.1016/j.molcel.2022.03.027. Epub 2022 Apr 15.

DOI:10.1016/j.molcel.2022.03.027
PMID:35429439
Abstract

YAP and TAZ (YAP/TAZ), two major effectors of the Hippo signaling pathway, are frequently activated in human cancers. The activity of YAP/TAZ is strictly repressed upon phosphorylation by LATS1/2 tumor suppressors. However, it is unclear how LATS1/2 are precisely regulated by upstream factors such as Hippo kinases MST1/2. Here, we show that WWC proteins (WWC1/2/3) directly interact with LATS1/2 and SAV1, and SAV1, in turn, brings in MST1/2 to phosphorylate and activate LATS1/2. Hence, WWC1/2/3 play an organizer role in a signaling module that mediates LATS1/2 activation by MST1/2. Moreover, we have defined a minimum protein interaction interface on WWC1/2/3 that is sufficient to activate LATS1/2 in a robust and specific manner. The corresponding minigene, dubbed as SuperHippo, can effectively suppress tumorigenesis in multiple tumor models. Our study has uncovered a molecular mechanism underlying LATS1/2 regulation and provides a strategy for treating diverse malignancies related to Hippo pathway dysregulation.

摘要

YAP 和 TAZ(YAP/TAZ)是 Hippo 信号通路的两个主要效应物,在人类癌症中经常被激活。YAP/TAZ 的活性在被 LATS1/2 肿瘤抑制物磷酸化时受到严格抑制。然而,目前尚不清楚 Hippo 激酶 MST1/2 等上游因子如何精确调控 LATS1/2。在这里,我们表明 WWC 蛋白(WWC1/2/3)直接与 LATS1/2 和 SAV1 相互作用,而 SAV1 反过来又将 MST1/2 带入,使其磷酸化并激活 LATS1/2。因此,WWC1/2/3 在一个信号模块中发挥组织者的作用,该模块通过 MST1/2 介导 LATS1/2 的激活。此外,我们已经确定了 WWC1/2/3 上的最小蛋白质相互作用界面,该界面足以以强大且特异性的方式激活 LATS1/2。这个被称为 SuperHippo 的最小基因可以有效地抑制多种肿瘤模型中的肿瘤发生。我们的研究揭示了 LATS1/2 调节的分子机制,并为治疗与 Hippo 通路失调相关的多种恶性肿瘤提供了一种策略。

相似文献

1
WWC proteins mediate LATS1/2 activation by Hippo kinases and imply a tumor suppression strategy.WWC 蛋白通过 Hippo 激酶介导 LATS1/2 的激活,并暗示了一种肿瘤抑制策略。
Mol Cell. 2022 May 19;82(10):1850-1864.e7. doi: 10.1016/j.molcel.2022.03.027. Epub 2022 Apr 15.
2
MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway.丝裂原活化蛋白激酶4家族激酶与MST1/2协同作用,在Hippo信号通路中激活LATS1/2。
Nat Commun. 2015 Oct 5;6:8357. doi: 10.1038/ncomms9357.
3
Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.血管生成素刺激 LATS 激酶自身磷酸化,并作为支架促进 Hippo 信号通路。
J Biol Chem. 2018 Nov 23;293(47):18230-18241. doi: 10.1074/jbc.RA118.004187. Epub 2018 Sep 28.
4
Inhibiting Hippo pathway kinases releases WWC1 to promote AMPAR-dependent synaptic plasticity and long-term memory in mice.抑制 Hippo 通路激酶会释放 WWC1,从而促进 AMPAR 依赖性突触可塑性和小鼠的长期记忆。
Sci Signal. 2024 Apr 30;17(834):eadj6603. doi: 10.1126/scisignal.adj6603.
5
WWC1 and NF2 Prevent the Development of Intrahepatic Cholangiocarcinoma by Regulating YAP/TAZ Activity through LATS in Mice.WWC1 和 NF2 通过调节 LATS 在小鼠中抑制 YAP/TAZ 活性从而预防肝内胆管细胞癌的发生。
Mol Cells. 2020 May 31;43(5):491-499. doi: 10.14348/molcells.2020.0093.
6
Transmembrane protein KIRREL1 regulates Hippo signaling via a feedback loop and represents a therapeutic target in YAP/TAZ-active cancers.跨膜蛋白 KIRREL1 通过反馈环调节 Hippo 信号通路,是 YAP/TAZ 活性癌症的治疗靶点。
Cell Rep. 2022 Aug 30;40(9):111296. doi: 10.1016/j.celrep.2022.111296.
7
Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner.鞘氨醇磷酸胆碱以双重方式调节Hippo信号通路。
Cell Signal. 2016 Dec;28(12):1894-1903. doi: 10.1016/j.cellsig.2016.09.004. Epub 2016 Sep 12.
8
Lipid kinase PIP5Kα contributes to Hippo pathway activation via interaction with Merlin and by mediating plasma membrane targeting of LATS1.脂质激酶 PIP5Kα 通过与 Merlin 相互作用,并介导 LATS1 向质膜定位,促进 Hippo 通路的激活。
Cell Commun Signal. 2023 Jun 19;21(1):149. doi: 10.1186/s12964-023-01161-w.
9
Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.miR-181c的上调通过使Hippo信号通路失活而导致胰腺癌的化疗耐药。
Oncotarget. 2015 Dec 29;6(42):44466-79. doi: 10.18632/oncotarget.6298.
10
MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway.丝裂原活化蛋白激酶激酶激酶2(MEKK2)和丝裂原活化蛋白激酶激酶激酶3(MEKK3)协调多种信号以调节Hippo信号通路。
J Biol Chem. 2021 Jan-Jun;296:100400. doi: 10.1016/j.jbc.2021.100400. Epub 2021 Feb 9.

引用本文的文献

1
Epithelial-Mesenchymal Transition Activates YAP to Drive Malignant Progression and Immune Evasion.上皮-间质转化激活YAP以驱动恶性进展和免疫逃逸。
Cancers (Basel). 2025 Aug 25;17(17):2767. doi: 10.3390/cancers17172767.
2
HOMER3 orchestrates SRC-YAP1 activity that promotes tumor cell growth and antagonizes anti-tumor immunotherapy in prostate cancer.HOMER3 协调 SRC-YAP1 活性,促进肿瘤细胞生长并拮抗前列腺癌中的抗肿瘤免疫治疗。
Oncogene. 2025 Aug 23. doi: 10.1038/s41388-025-03548-0.
3
OMVs inhibit osteogenic differentiation of BMSCs via SAA3/TLR4/MyD88/NF-κB axis.
外膜囊泡通过血清淀粉样蛋白A3/ Toll样受体4/髓样分化因子88/核因子κB轴抑制骨髓间充质干细胞的成骨分化。
J Oral Microbiol. 2025 Aug 8;17(1):2540823. doi: 10.1080/20002297.2025.2540823. eCollection 2025.
4
Unraveling the Hippo pathway: YAP/TAZ as central players in cancer metastasis and drug resistance.解析河马通路:YAP/TAZ在癌症转移和耐药性中扮演核心角色。
EXCLI J. 2025 Jun 6;24:612-637. doi: 10.17179/excli2025-8351. eCollection 2025.
5
Kibra knockdown inhibits the aberrant Hippo pathway, suppresses renal cyst formation and ameliorates renal fibrosis in nphp1 mice.敲低Kibra可抑制异常的Hippo信号通路,抑制nphp1小鼠肾囊肿形成并改善肾纤维化。
Clin Transl Med. 2025 Mar;15(3):e70245. doi: 10.1002/ctm2.70245.
6
WWC proteins-mediated compensatory mechanism restricts schwannomatosis driven by loss of function.WWC蛋白介导的代偿机制限制了由功能丧失驱动的神经鞘瘤病。
Sci Adv. 2025 Jan 24;11(4):eadp4765. doi: 10.1126/sciadv.adp4765. Epub 2025 Jan 22.
7
WWC2 modulates GABA-receptor-mediated synaptic transmission, revealing class-specific mechanisms of synapse regulation by WWC family proteins.WWC2 调节 GABA 受体介导的突触传递,揭示了 WWC 家族蛋白调节突触的类特异性机制。
Cell Rep. 2024 Oct 22;43(10):114841. doi: 10.1016/j.celrep.2024.114841. Epub 2024 Oct 10.
8
Gene therapy for diffuse pleural mesotheliomas in preclinical models by concurrent expression of NF2 and SuperHippo.通过同时表达 NF2 和 SuperHippo 对间皮瘤进行临床前模型的基因治疗。
Cell Rep Med. 2024 Oct 15;5(10):101763. doi: 10.1016/j.xcrm.2024.101763. Epub 2024 Oct 4.
9
YAP/TAZ as mechanobiological signaling pathway in cardiovascular physiological regulation and pathogenesis.YAP/TAZ作为心血管生理调节和发病机制中的机械生物学信号通路。
Mechanobiol Med. 2024 Dec;2(4). doi: 10.1016/j.mbm.2024.100085. Epub 2024 Aug 9.
10
Circular RNA circ_ARHGEF28 inhibits MST1/2 dimerization to suppress Hippo pathway to induce cisplatin resistance in ovarian cancer.环状RNA circ_ARHGEF28通过抑制MST1/2二聚化来抑制Hippo信号通路,从而诱导卵巢癌顺铂耐药。
Cancer Cell Int. 2024 Jul 21;24(1):256. doi: 10.1186/s12935-024-03451-w.